Sep 9, 2009
By:Sarah Houlton
With a weak pound being outpaced by the euro, many hospitals are sending drugs to the Continent for higher profits. What can NHS do to stop this practice?
 |
Jul 22, 2009
By:Sarah Houlton
Statins should be given to people with high blood pressure or diabetes, even if they don?t have heart disease, according to a study published in the British Medical Journal.
|
Jul 8, 2009
By:Sarah Houlton
UK Health Institute leaves guidance unchanged in case against Eisai and Pfizer; more research on NICE methodology needed.
|
May 21, 2009
By:Sarah Houlton
Diversity of ethnic groups and prevalence of Spanish language make Latin America an attractive destination for clinical trials.
|
Mar 11, 2009
By:Sarah Houlton
It could be the end of the road for the UK's biotech firms if drastic action isn't taken soon.
|
Feb 1, 2009
By:Sarah Houlton
EC proposal loosens restrictions on drug packaging and information dissemination.
|
Dec 1, 2008
By:Sarah Houlton
The new EU directive looks to reduce, refine, and eventually replace animal testing
|
In Europe, state controlled healthcare decisions create as many problems as they do answers
Nov 1, 2008
By:Sarah Houlton
In Europe, it's different strokes for different folks at the top regulatory agencies
|
Oct 1, 2008
By:Sarah Houlton
Tensions mount as stakeholders in the UK health industry attempt to work out drug cost problems
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
Applying E-Commerce to Support Discovery and Development of Medicines: Key Lessons and Learnings Tuesday, December 15 @ 11:00 a.m. ET
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?